Skip to content

Maravai LifeSciences Holdings, Inc. MRVI Payments For (Proceeds From) Tax Liabilities With Non-Controlling Interests

Payments For (Proceeds From) Tax Liabilities With Non-Controlling Interests at other companies

GCM Grosvenor Inc. logo
GCM Grosvenor Inc.GCMG
$4.05M-22.0%
Tidewater logo
TidewaterTDW
$0
Virtu Financial logo
Virtu FinancialVIRT
$114.49M+20.9%
StepStone Group Inc. logo
StepStone Group Inc.STEP
$10.34M+91.5%
Lazard logo
LazardLAZ
$10.22M
REX American Resources logo
REX American ResourcesREX
$0-100%

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$902.74M+204%
Enterprise value$1.01B+198%
P/S4.4×+3.2×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept mrvi:PaymentsForProceedsFromTaxLiabilitiesWithNonControllingInterests.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s payments for (proceeds from) tax liabilities with non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s payments for (proceeds from) tax liabilities with non-controlling interests?
Maravai LifeSciences Holdings, Inc. (MRVI) reported payments for (proceeds from) tax liabilities with non-controlling interests of -$2.5K in Q4 2025.
How has Maravai LifeSciences Holdings, Inc.'s payments for (proceeds from) tax liabilities with non-controlling interests changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s payments for (proceeds from) tax liabilities with non-controlling interests decreased by 102.0% year-over-year, from $123.5K to -$2.5K.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s payments for (proceeds from) tax liabilities with non-controlling interests?
Over 2 years (2023 to 2025), Maravai LifeSciences Holdings, Inc.'s payments for (proceeds from) tax liabilities with non-controlling interests has grown at a -96.8% compound annual growth rate (CAGR), from $9.61M to -$10K.
What does payments for (proceeds from) tax liabilities with non-controlling interests mean?
This metric tracks cash flows related to the settlement of tax liabilities associated with non-controlling interests in consolidated subsidiaries. It reflects the company's obligation to manage tax distributions or payments on behalf of minority partners. Monitoring this helps investors understand the cash impact of complex ownership structures on the parent company's liquidity.